IL6 and atherosclerosis: From a cardiovascular perspective, CHIP is associated with accelerated atherosclerosis, as genes encoded by CHIP are also involved in de-activation of interleukin-6 (IL-6), ultimately leading to increased circulating levels of IL-6 and increased inflammation [14, 15].